JAK2 and pulmonary arterial hypertension: It can be inferred that JAK2 is involved in pulmonary vascular remodeling and the formation of pulmonary hypertension, supported by rats treated with intratracheal bleomycin and the PASMCs and PAECs in pulmonary arteries of IPF patients [112].